93 related articles for article (PubMed ID: 16152589)
1. The steroid receptor RNA activator protein is expressed in breast tumor tissues.
Chooniedass-Kothari S; Hamedani MK; Troup S; Hubé F; Leygue E
Int J Cancer; 2006 Feb; 118(4):1054-9. PubMed ID: 16152589
[TBL] [Abstract][Full Text] [Related]
2. Steroid Receptor RNA Activator Protein (SRAP): a potential new prognostic marker for estrogen receptor-positive/node-negative/younger breast cancer patients.
Yan Y; Skliris GP; Penner C; Chooniedass-Kothari S; Cooper C; Nugent Z; Blanchard A; Watson PH; Myal Y; Murphy LC; Leygue E
Breast Cancer Res; 2009; 11(5):R67. PubMed ID: 19740422
[TBL] [Abstract][Full Text] [Related]
3. Alternative splicing of the first intron of the steroid receptor RNA activator (SRA) participates in the generation of coding and noncoding RNA isoforms in breast cancer cell lines.
Hube F; Guo J; Chooniedass-Kothari S; Cooper C; Hamedani MK; Dibrov AA; Blanchard AA; Wang X; Deng G; Myal Y; Leygue E
DNA Cell Biol; 2006 Jul; 25(7):418-28. PubMed ID: 16848684
[TBL] [Abstract][Full Text] [Related]
4. Increasing the relative expression of endogenous non-coding Steroid Receptor RNA Activator (SRA) in human breast cancer cells using modified oligonucleotides.
Cooper C; Guo J; Yan Y; Chooniedass-Kothari S; Hube F; Hamedani MK; Murphy LC; Myal Y; Leygue E
Nucleic Acids Res; 2009 Jul; 37(13):4518-31. PubMed ID: 19483093
[TBL] [Abstract][Full Text] [Related]
5. Expression of both estrogen receptor-beta 1 (ER-β1) and its co-regulator steroid receptor RNA activator protein (SRAP) are predictive for benefit from tamoxifen therapy in patients with estrogen receptor-alpha (ER-α)-negative early breast cancer (EBC).
Yan Y; Li X; Blanchard A; Bramwell VH; Pritchard KI; Tu D; Shepherd L; Myal Y; Penner C; Watson PH; Leygue E; Murphy LC
Ann Oncol; 2013 Aug; 24(8):1986-93. PubMed ID: 23579816
[TBL] [Abstract][Full Text] [Related]
6. The steroid receptor RNA activator protein (SRAP) controls cancer cell migration/motility.
Yan Y; Cooper C; Hamedani MK; Guppy B; Xu W; Tsuyuki D; Zhang C; Nugent Z; Blanchard A; Davie JR; McManus K; Murphy LC; Myal Y; Leygue E
FEBS Lett; 2015 Dec; 589(24 Pt B):4010-8. PubMed ID: 26581859
[TBL] [Abstract][Full Text] [Related]
7. Structure and function of steroid receptor RNA activator protein, the proposed partner of SRA noncoding RNA.
McKay DB; Xi L; Barthel KKB; Cech TR
J Mol Biol; 2014 Apr; 426(8):1766-1785. PubMed ID: 24486609
[TBL] [Abstract][Full Text] [Related]
8. Steroid receptor RNA activator (SRA1): unusual bifaceted gene products with suspected relevance to breast cancer.
Leygue E
Nucl Recept Signal; 2007 Aug; 5():e006. PubMed ID: 17710122
[TBL] [Abstract][Full Text] [Related]
9. Leptin attenuates the anti-estrogen effect of tamoxifen in breast cancer.
Chen X; Zha X; Chen W; Zhu T; Qiu J; Røe OD; Li J; Wang Z; Yin Y
Biomed Pharmacother; 2013 Feb; 67(1):22-30. PubMed ID: 23199901
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M
Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749
[TBL] [Abstract][Full Text] [Related]
11. Identification of new human coding steroid receptor RNA activator isoforms.
Emberley E; Huang GJ; Hamedani MK; Czosnek A; Ali D; Grolla A; Lu B; Watson PH; Murphy LC; Leygue E
Biochem Biophys Res Commun; 2003 Feb; 301(2):509-15. PubMed ID: 12565891
[TBL] [Abstract][Full Text] [Related]
12. MAP kinase/estrogen receptor cross-talk enhances estrogen-mediated signaling and tumor growth but does not confer tamoxifen resistance.
Atanaskova N; Keshamouni VG; Krueger JS; Schwartz JA; Miller F; Reddy KB
Oncogene; 2002 Jun; 21(25):4000-8. PubMed ID: 12037682
[TBL] [Abstract][Full Text] [Related]
13. Steroid receptor RNA activator protein (SRAP) expression as a prognostic factor in ER+ human breast tumors.
Yan Y; Penner CC; Skliris GP; Cooper C; Nugent Z; Blanchard A; Hamedani MK; Wang X; Myal Y; Murphy LC; Leygue E
J Cancer Res Clin Oncol; 2013 Oct; 139(10):1637-47. PubMed ID: 23907597
[TBL] [Abstract][Full Text] [Related]
14. Menin, a product of the MENI gene, binds to estrogen receptor to enhance its activity in breast cancer cells: possibility of a novel predictive factor for tamoxifen resistance.
Imachi H; Murao K; Dobashi H; Bhuyan MM; Cao X; Kontani K; Niki S; Murazawa C; Nakajima H; Kohno N; Yamashita H; Iwase H; Hayashi S; Ishida T; Yamauchi A
Breast Cancer Res Treat; 2010 Jul; 122(2):395-407. PubMed ID: 19847644
[TBL] [Abstract][Full Text] [Related]
15. High tumoral levels of Kiss1 and G-protein-coupled receptor 54 expression are correlated with poor prognosis of estrogen receptor-positive breast tumors.
Marot D; Bieche I; Aumas C; Esselin S; Bouquet C; Vacher S; Lazennec G; Perricaudet M; Kuttenn F; Lidereau R; de Roux N
Endocr Relat Cancer; 2007 Sep; 14(3):691-702. PubMed ID: 17914099
[TBL] [Abstract][Full Text] [Related]
16. Aurora kinase B is important for antiestrogen resistant cell growth and a potential biomarker for tamoxifen resistant breast cancer.
Larsen SL; Yde CW; Laenkholm AV; Rasmussen BB; Duun-Henriksen AK; Bak M; Lykkesfeldt AE; Kirkegaard T
BMC Cancer; 2015 Apr; 15():239. PubMed ID: 25885472
[TBL] [Abstract][Full Text] [Related]
17. A metastatic breast tumor cell line, GI-101A, is estrogen receptor positive and responsive to estrogen but resistant to tamoxifen.
Morrissey JJ; Raney S
Cell Biol Int; 1998; 22(6):413-9. PubMed ID: 10328849
[TBL] [Abstract][Full Text] [Related]
18. Acquisition of epithelial-mesenchymal transition phenotype in the tamoxifen-resistant breast cancer cell: a new role for G protein-coupled estrogen receptor in mediating tamoxifen resistance through cancer-associated fibroblast-derived fibronectin and β1-integrin signaling pathway in tumor cells.
Yuan J; Liu M; Yang L; Tu G; Zhu Q; Chen M; Cheng H; Luo H; Fu W; Li Z; Yang G
Breast Cancer Res; 2015 May; 17(1):69. PubMed ID: 25990368
[TBL] [Abstract][Full Text] [Related]
19. A novel steroid receptor co-activator protein (SRAP) as an alternative form of steroid receptor RNA-activator gene: expression in prostate cancer cells and enhancement of androgen receptor activity.
Kawashima H; Takano H; Sugita S; Takahara Y; Sugimura K; Nakatani T
Biochem J; 2003 Jan; 369(Pt 1):163-71. PubMed ID: 12350225
[TBL] [Abstract][Full Text] [Related]
20. Keratinocyte growth factor (KGF) induces tamoxifen (Tam) resistance in human breast cancer MCF-7 cells.
Chang HL; Sugimoto Y; Liu S; Ye W; Wang LS; Huang YW; Lin YC
Anticancer Res; 2006; 26(3A):1773-84. PubMed ID: 16827106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
